Volume 5, Issue 2

• FDA Provides New Guidance on Antipsychotic Usage during Pregnancy
  Author(s): Peter F. Buckley
  • Abstract
  • PDF
• Impact of Complete Blood Count Sampling Time Change on White Blood Cell and Absolute Neutrophil Count Values in Clozapine Recipients
  Author(s): Jerry R. McKee, Trossie Wall , Jessica Owensby
  • Abstract
  • PDF
• Schizophrenia Treatment Guidelines in the United States
  Author(s): Troy A. Moore
  • Abstract
• Obstetrical Complications, Social Class and Type of Schizophrenia
  Author(s): Brian J. Jones, Bernard J. Gallagher III, Dana M. Moss, Joseph A. McFalls Jr.
  • Abstract
  • PDF
• Placebo-Controlled Trial of Atomoxetine for Weight Reduction in People with Schizophrenia Treated with Clozapine or Olanzapine
  Author(s): M. Patricia Ball, Kimberly R. Warren, Stephanie Feldman, Robert P. McMahon,Deanna L. Kelly, Robert W. Buchanan
  • Abstract
• Implementing Treatment Guidelines
  Author(s): Alexander L. Miller
  • Abstract
  • PDF
• A Potential Case of Peduncular Hallucinosis Treated Successfully with Olanzapine
  Author(s): David Spiegel , Jessica Barber , Margarita Somova
  • Abstract
  • PDF
• Cardiometabolic Conditions in Patients with Schizophrenia
  Author(s): Jeanette M. Jerrell
  • Abstract
  • PDF